AAAAAA

   
Results: 1-8 |
Results: 8
RADIATION-THERAPY FOR RHABDOMYOSARCOMA - LOCAL FAILURE RISK FOR CLINICAL GROUP-III PATIENTS ON INTERGROUP RHABDOMYOSARCOMA STUDY-II
Authors: WHARAM MD HANFELT JJ TEFFT MC JOHNSTON J ENSIGN LG BRENEMAN J DONALDSON SS FRYER C GEHAN EA RANEY RB MAURER HM
Citation: Md. Wharam et al., RADIATION-THERAPY FOR RHABDOMYOSARCOMA - LOCAL FAILURE RISK FOR CLINICAL GROUP-III PATIENTS ON INTERGROUP RHABDOMYOSARCOMA STUDY-II, International journal of radiation oncology, biology, physics, 38(4), 1997, pp. 797-804
MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS AND CRYPTOCOCCUS-NEOFORMANS WITH AND WITHOUT AGITATION - AN 8-CENTER COLLABORATIVE STUDY
Authors: ANAISSIE EJ PAETZNICK VL ENSIGN LG ESPINELINGROFF A GALGIANI JN HITCHCOCK CA LAROCCO M PATTERSON T PFALLER MA REX JH RINALDI MG
Citation: Ej. Anaissie et al., MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTING OF CANDIDA-ALBICANS AND CRYPTOCOCCUS-NEOFORMANS WITH AND WITHOUT AGITATION - AN 8-CENTER COLLABORATIVE STUDY, Antimicrobial agents and chemotherapy, 40(10), 1996, pp. 2387-2391
AN OPTIMAL 3-STAGE DESIGN FOR PHASE-II CLINICAL-TRIALS
Authors: ENSIGN LG GEHAN EA KAMEN DS THALL PF
Citation: Lg. Ensign et al., AN OPTIMAL 3-STAGE DESIGN FOR PHASE-II CLINICAL-TRIALS, Statistics in medicine, 13(17), 1994, pp. 1727-1736
RENAL TOXICITY OF IFOSFAMIDE IN PILOT REGIMENS OF THE INTERGROUP RHABDOMYOSARCOMA STUDY FOR PATIENTS WITH GROSS RESIDUAL TUMOR
Authors: RANEY B ENSIGN LG FOREMAN J KHAN F NEWTON W ORTEGA J RAGAB A WHARAM M WIENER E MAURER H
Citation: B. Raney et al., RENAL TOXICITY OF IFOSFAMIDE IN PILOT REGIMENS OF THE INTERGROUP RHABDOMYOSARCOMA STUDY FOR PATIENTS WITH GROSS RESIDUAL TUMOR, The American journal of pediatric hematology/oncology, 16(4), 1994, pp. 286-295
INTERPHASE CYTOGENETICS IN PARAFFIN-EMBEDDED SECTIONS FROM RENAL CORTICAL NEOPLASMS - CORRELATION WITH CYTOGENETIC AND FLOW CYTOMETRIC DNA-PLOIDY ANALYSES
Authors: ELNAGGAR AK VANDEKKEN HD ENSIGN LG PATHAK S
Citation: Ak. Elnaggar et al., INTERPHASE CYTOGENETICS IN PARAFFIN-EMBEDDED SECTIONS FROM RENAL CORTICAL NEOPLASMS - CORRELATION WITH CYTOGENETIC AND FLOW CYTOMETRIC DNA-PLOIDY ANALYSES, Cancer genetics and cytogenetics, 73(2), 1994, pp. 134-141
ACUTE MYELOID-LEUKEMIA IN PATIENTS TREATED FOR RHABDOMYOSARCOMA WITH CYCLOPHOSPHAMIDE AND LOW-DOSE ETOPOSIDE ON INTERGROUP RHABDOMYOSARCOMASTUDY .3. AN INTERIM-REPORT
Authors: HEYN R KHAN F ENSIGN LG DONALDSON SS RUYMANN F SMITH MA VIETTI T MAURER HM
Citation: R. Heyn et al., ACUTE MYELOID-LEUKEMIA IN PATIENTS TREATED FOR RHABDOMYOSARCOMA WITH CYCLOPHOSPHAMIDE AND LOW-DOSE ETOPOSIDE ON INTERGROUP RHABDOMYOSARCOMASTUDY .3. AN INTERIM-REPORT, Medical and pediatric oncology, 23(2), 1994, pp. 99-106
SURGICAL-MANAGEMENT AND PROGNOSTIC FACTORS IN PATIENTS WITH SUBUNGUALMELANOMA
Authors: HEATON KM ELNAGGAR A ENSIGN LG ROSS MI BALCH CM
Citation: Km. Heaton et al., SURGICAL-MANAGEMENT AND PROGNOSTIC FACTORS IN PATIENTS WITH SUBUNGUALMELANOMA, Annals of surgery, 219(2), 1994, pp. 197-204
2-SITE COMPARISON OF BROTH MICRODILUTION AND SEMISOLID AGAR DILUTION METHODS FOR SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS IN 3 MEDIA
Authors: ANAISSIE E SHAWAR R PAETZNICK V ENSIGN LG WITTE Z LAROCCO M
Citation: E. Anaissie et al., 2-SITE COMPARISON OF BROTH MICRODILUTION AND SEMISOLID AGAR DILUTION METHODS FOR SUSCEPTIBILITY TESTING OF CRYPTOCOCCUS-NEOFORMANS IN 3 MEDIA, Journal of clinical microbiology, 31(5), 1993, pp. 1370-1372
Risultati: 1-8 |